InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Miller Langdon L, Directeur Médical. Director active across 1 companies, notably Cleveland Biolabs INC. In total, 2 disclosures have been published. The latest transaction was filed on 22 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€25,48310,000 shares@ €2.5483100.0% of flow
Common Stock, par value $0.005 per share
SEC:0001437749-21-017452·
€25,48310,000 shares@ €2.548350.0% of flow
Common Stock, par value $0.005 per share
SEC:0001437749-21-017452:0·
2 of 2 declarations
About Miller Langdon L
Langdon L. Miller serves as Chief Medical Officer at Cleveland Biolabs Inc. In this role, he oversees the medical and scientific activities of the company. Langdon is responsible for directing clinical research and innovation in the development of new treatments. His medical expertise is essential to ensure that the company's products meet safety and efficacy standards.
